We are live on ! Find out more
FLNA

Filana Therapeutics
FLNA

140 hedge funds and large institutions have $215M invested in Filana Therapeutics in 2023 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 55 increasing their positions, 31 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

77% more repeat investments, than reductions

Existing positions increased: 55 | Existing positions reduced: 31

11% more call options, than puts

Call options by funds: $65.2M | Put options by funds: $58.7M

2.81% more ownership

Funds ownership: 28.02% → 30.83% (+2.8%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

8% less funds holding

Funds holding: 152 → 140 (-12)

25% less capital invested

Capital invested by funds: $287M → $215M (-$71.4M)

36% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 25

Holders
140
Holders Change
-12
Holders Change %
-7.89%
% of All Funds
2.22%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
16
Increased
55
Reduced
31
Closed
25
Calls
$65.2M
Puts
$58.7M
Net Calls
+$6.47M
Net Calls Change
+$3.48M

Top Buyers

Rank Fund Capital Flow
1
Bank of America
Bank of America
North Carolina
+$8.88M
2
Morgan Stanley
Morgan Stanley
New York
+$5.19M
3
SC
Sculptor Capital
New York
+$4.46M
4
CF
Cantor Fitzgerald
New York
+$3.38M
5
SG Americas Securities
SG Americas Securities
New York
+$2.55M

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$3.15M
2
Citadel Advisors
Citadel Advisors
Florida
-$2.84M
3
Norges Bank
Norges Bank
Norway
-$1.16M
4
N
Nuveen
North Carolina
-$968K
5
Group One Trading
Group One Trading
Illinois
-$910K
Name Holding Trade Value Shares
Change 		Change in
Stake
S
126
SignatureFD
Georgia
$1.33K +$713 +36 +82%
SWA
127
SOA Wealth Advisors
New York
$1.3K – – –
SPIA
128
Steward Partners Investment Advisory
New York
$1.25K – – –
GWM
129
Geneos Wealth Management
Colorado
$1.25K +$1.49K +75 New
FCMT
130
Founders Capital Management (Texas)
Texas
$1.17K – – –
AF
131
Allworth Financial
California
$966 +$1.15K +58 New
HPC
132
HM Payson & Co
Maine
$832 – – –
NA
133
NewEdge Advisors
Louisiana
$832 – – –
SSB
134
Sandy Spring Bank
Maryland
$832 – – –
CWA
135
Carolina Wealth Advisors
South Carolina
$798 – – –
SWA
136
Sutton Wealth Advisors
Florida
$549 +$654 +33 New
HGERS
137
Householder Group Estate & Retirement Specialist
Arizona
$250 +$297 +15 New
PA
138
Parallel Advisors
California
$166 – – –
EWA
139
EverSource Wealth Advisors
Alabama
$83 – – –
Group One Trading
140
Group One Trading
Illinois
– -$910K -45,936 Closed
Simplex Trading
141
Simplex Trading
Illinois
– -$768K -38,751 Closed
Squarepoint
142
Squarepoint
New York
– -$803K -32,755 Closed
GS
143
GTS Securities
New York
– -$601K -30,336 Closed
Walleye Trading
144
Walleye Trading
New York
– -$535K -27,009 Closed
Marshall Wace
145
Marshall Wace
United Kingdom
– -$597K -24,348 Closed
TC
146
TwinBeech Capital
New York
– -$505K -20,588 Closed
Wolverine Trading
147
Wolverine Trading
Illinois
– -$356K -17,987 Closed
HF
148
HRT Financial
New York
– -$378K -15,417 Closed
Baird Financial Group
149
Baird Financial Group
Wisconsin
– -$344K -14,020 Closed
Creative Planning
150
Creative Planning
Kansas
– -$309K -12,616 Closed
3 4 5
6
7

FLNA Hedge Fund Activity: Q3 2023 in Review

140 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Filana Therapeutics (FLNA) for Q3 2023, worth a combined $215M — down 25% from $287M a quarter earlier.

Sellers outnumbered buyers: 25 funds closed out of FLNA and 16 opened new positions — a net loss of 9 holders — while 31 trimmed existing stakes and 55 added.

The largest buyer was Bank of America, adding an estimated $8.88M. The largest seller was Susquehanna International Group, cutting an estimated $3.15M.

  • 140 institutional investors held Filana Therapeutics (FLNA) as of Q3 2023, down from 152 in Q2 2023.
  • Funds reported $215M of Filana Therapeutics stock for Q3 2023, down 25% quarter-over-quarter.
  • 16 funds opened new Filana Therapeutics positions in Q3 2023 and 25 closed out, a net change of -9 holders.
  • The largest Filana Therapeutics buyer in Q3 2023 was Bank of America, an estimated $8.88M added.
  • The largest Filana Therapeutics seller in Q3 2023 was Susquehanna International Group, an estimated $3.15M sold.

Based on aggregated 13F filings for Q3 2023.